results

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca plc (NYSE: AZN) released a bevy of news today, including Q2 results, as well as study results for two drugs. AZN price has plummeted 15%.Following the loss of exclusivity for Crestor and Seroquel XR AstraZeneca had expected losses in the..

Anthem Announced Second-Quarter Earnings, Beating Expectations

Anthem Announced Second-Quarter Earnings, Beating Expectations

On Wednesday, Anthem, Inc. (NYSE: ANTM) announced its financial results for the second quarter of 2017, with earnings beating estimates but revenue missing expectations.The company said that net income for the second quarter increased from $780.6 mi..

Accenture Plc Shares Fall After Earnings Report Disappoints

Accenture Plc Shares Fall After Earnings Report Disappoints

Accenture Plc (NYSE: ACN) shares fell about 4% Thursday after the company reported financial results for the third quarter of fiscal 2017, ended May 31, 2017, with net revenues of $8.9 billion, an increase of 5 percent in U.S. dollars and 7 per..